Balance Sheet
Cash Flow Statement
AmortizationAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShares IssuedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evogene (EVGN) Other financing activities (2016 - 2025)

Historic Other financing activities for Evogene (EVGN) over the last 12 years, with Q3 2025 value amounting to -$226000.0.

  • Evogene's Other financing activities fell 70714.29% to -$226000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$9000.0, marking a year-over-year increase of 5909.09%. This contributed to the annual value of $84000.0 for FY2024, which is 9228.65% down from last year.
  • As of Q3 2025, Evogene's Other financing activities stood at -$226000.0, which was down 70714.29% from $6000.0 recorded in Q2 2025.
  • Evogene's 5-year Other financing activities high stood at $1.1 million for Q2 2023, and its period low was -$226000.0 during Q3 2025.
  • Its 5-year average for Other financing activities is $119470.6, with a median of $32000.0 in 2021.
  • As far as peak fluctuations go, Evogene's Other financing activities skyrocketed by 42500.0% in 2024, and later plummeted by 70714.29% in 2025.
  • Over the past 5 years, Evogene's Other financing activities (Quarter) stood at $32000.0 in 2021, then surged by 87.5% to $60000.0 in 2022, then plummeted by 66.67% to $20000.0 in 2023, then soared by 425.0% to $105000.0 in 2024, then tumbled by 315.24% to -$226000.0 in 2025.
  • Its last three reported values are -$226000.0 in Q3 2025, $6000.0 for Q2 2025, and $106000.0 during Q1 2025.